Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Adam G. Stewart, David L. Paterson, Barnaby Young, David C. Lye, Joshua S. Davis, Kellie Schneider, Mesut Yilmaz, Rumeysa Dinleyici, Naomi Runnegar, Andrew Henderson, Sophia Archuleta, Shirin Kalimuddin, Brian M. Forde, Mark D. Chatfield, Michelle J. Bauer, Jeffrey Lipman, Tiffany Harris-Brown, Patrick N.A. Harris

    Research output: Contribution to journalArticlepeer-review

    8 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)'. Together they form a unique fingerprint.

    Medicine & Life Sciences